Shen Y - Search Results

1

Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow.

Seong D, Thall P, Kantarjian HM, Talpaz M, Swantkowski J, Xu J, Shen Y, Glassman A, Ramagli L, Siciliano MJ. Seong D, et al. Among authors: shen y. Clin Cancer Res. 1998 Apr;4(4):861-7. Clin Cancer Res. 1998. PMID: 9563879

2

Parametric likelihoods for multiple non-fatal competing risks and death.

Shen Y, Thall PF. Shen Y, et al. Stat Med. 1998 May 15;17(9):999-1015. doi: 10.1002/(sici)1097-0258(19980515)17:9<999::aid-sim785>3.0.co;2-3. Stat Med. 1998. PMID: 9612887

3

Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB.

Estey EH, Shen Y, Thall PF. Estey EH, et al. Among authors: shen y. Blood. 2000 Jan 1;95(1):72-7. Blood. 2000. PMID: 10607687 Free article.

4

Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair.

Yang LY, Li L, Jiang H, Shen Y, Plunkett W. Yang LY, et al. Among authors: shen y. Clin Cancer Res. 2000 Mar;6(3):773-81. Clin Cancer Res. 2000. PMID: 10741696

5

Approximate Bayesian evaluation of multiple treatment effects.

Thall PF, Simon RM, Shen Y. Thall PF, et al. Among authors: shen y. Biometrics. 2000 Mar;56(1):213-9. doi: 10.1111/j.0006-341x.2000.00213.x. Biometrics. 2000. PMID: 10783798

6

High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia.

Cortes J, Estey E, O'Brien S, Giles F, Shen Y, Koller C, Beran M, Thomas D, Keating M, Kantarjian H. Cortes J, et al. Among authors: shen y. Cancer. 2001 Jul 1;92(1):7-14. doi: 10.1002/1097-0142(20010701)92:1<7::aid-cncr1285>3.0.co;2-d. Cancer. 2001. PMID: 11443603 Clinical Trial.

7

High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.

Beran M, Shen Y, Kantarjian H, O'Brien S, Koller CA, Giles FJ, Cortes J, Thomas DA, Faderl S, Despa S, Estey EH. Beran M, et al. Among authors: shen y. Cancer. 2001 Oct 15;92(8):1999-2015. doi: 10.1002/1097-0142(20011015)92:8<1999::aid-cncr1538>3.0.co;2-b. Cancer. 2001. PMID: 11596013

8

Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival.

Giles FJ, Shen Y, Kantarjian HM, Korbling MJ, O'Brien S, Anderlini P, Donato M, Pierce S, Keating MJ, Freireich EJ, Estey E. Giles FJ, et al. Among authors: shen y. Leuk Lymphoma. 2001 Jun;42(1-2):67-73. doi: 10.3109/10428190109097677. Leuk Lymphoma. 2001. PMID: 11699223

9

[Retrospective cohort study on the prognosis of chronic myeloid leukemia].

Liang X, Lin G, Zhang W, Shen Y, Tang Z, Wu W. Liang X, et al. Among authors: shen y. Zhonghua Nei Ke Za Zhi. 2000 Dec;39(12):835-7. Zhonghua Nei Ke Za Zhi. 2000. PMID: 11798548 Chinese.

10

Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome.

Lai R, Estey E, Shen Y, Despa S, Kantarjian H, Beran M, Maushouri T, Quackenbuch RC, Keating M, Albitar M. Lai R, et al. Among authors: shen y. Cancer. 2002 Jan 1;94(1):14-7. doi: 10.1002/cncr.10200. Cancer. 2002. PMID: 11815955 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,524 results

Search Page

Filters